Items where authors include "Khatib, R"

Article

Khatib, R orcid.org/0000-0001-9707-234X, Angus, N, Hansen, TB et al. (4 more authors) (2022) Perceptions of injectable therapies with cardiovascular benefit: an ACNAP survey of healthcare professionals to explore facilitators and barriers. European Journal of Cardiovascular Nursing, 21 (5). pp. 430-437. ISSN 1474-5151

Sofia, N, Mühlebach, S, Musazzi, UM et al. (6 more authors) (2021) How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries. Pharmaceutics, 13 (7). 1010. ISSN 1999-4923

Lambrinou, E, Kyriakou, M, Lakatamitou, I et al. (6 more authors) (2020) An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: A part of the ACNAP project ‘injectable medicines among patients with cardiovascular conditions’. European Journal of Cardiovascular Nursing, 19 (8). pp. 663-680. ISSN 1474-5151

Khatib, R orcid.org/0000-0001-9707-234X and Keenan, J (2020) Optimising secondary prevention and cardiovascular care across Europe: A UK perspective on a common goal. European Journal of Cardiovascular Nursing, 19 (7). pp. 653-654. ISSN 1474-5151

Slater, TA orcid.org/0000-0001-9213-5559, Drozd, M orcid.org/0000-0003-0255-4624, Palin, V et al. (5 more authors) (2020) Prescribing diabetes medication for cardiovascular risk reduction in patients admitted with acute coronary syndromes: a survey of cardiologists’ attitudes and practice. European Heart Journal - Cardiovascular Pharmacotherapy, 6 (3). pp. 194-196. ISSN 2055-6837

Khatib, R orcid.org/0000-0001-9707-234X, Patel, N and Hall, AS (2020) The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility. BMC Cardiovascular Disorders, 20. 46. ISSN 1471-2261

Khatib, R orcid.org/0000-0001-9707-234X, Marshall, K, Silcock, J et al. (2 more authors) (2019) Adherence to coronary artery disease secondary prevention medicines: Exploring modifiable barriers. Open Heart, 6 (2). ARTN: 000997.

Khatib, R orcid.org/0000-0001-9707-234X, Patel, N, Laverty, U et al. (4 more authors) (2018) Re-engineering the post-myocardial infarction medicines optimisation pathway: A retrospective analysis of a joint consultant pharmacist and cardiologist clinic model. Open Heart, 5 (2). e000921. ISSN 2053-3624

Al-Dewik, N, Morsi, HM, Samara, MM et al. (11 more authors) (2016) Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar? Clinical Medicine Insights: Oncology (10). pp. 95-104.

Petty, D and Khatib, R (2015) Dose optimisation following myocardial infarction. Prescriber, 26 (5). 29 - 31. ISSN 0959-6682

Other

Khatib, R (2015) Heart Failure. Communications International Group.